From discovery to delivery: Finding an investment edge in biopharma services
Even though the biopharma supply chain is a dynamic and complex part of the pharmaceutical industry, private equity investors can find growth and value creation opportunities. Here’s how.
![From discovery to delivery: Finding an investment edge in biopharma services](https://www.mckinsey.com/~/media/mckinsey/industries/private%20equity%20and%20principal%20investors/our%20insights/from%20discovery%20to%20delivery%20finding%20an%20investment%20edge%20in%20biopharma%20services/from-discovery-to-delivery-1343523149-thumb-1536x1536.jpg)